has a buy call on J B Chemicals & Pharmaceuticals with a target price of Rs 1456. The current market price of J B Chemicals is Rs 1229.45.

J B Chemicals & Pharmaceuticals, incorporated in the year 1976, is a mid cap company with a market cap of Rs 9,541.25 crore, operating in pharmaceuticals sector.

J B Chemicals & Pharmaceuticals key products/revenue segments include pharmaceuticals, export incentives, other operating revenue and scrap for the year ending 31-Mar-2020.

Investment rationale

The brokerage remains positive considering ~45 per cent of total revenues and ~60 per cent of EBITDA contribution is from domestic formulations with strong growth visibility coupled with focus on improving productivity, portfolio expansion and cost optimisation.

Financials
For the quarter ended 31-12-2020, the company has reported a consolidated total income of Rs 604.17 crore, up 33.68 per cent from last quarters total income of Rs 451.96 crore and up 35.76 per cent from last year same quarters total income of Rs 445.01 crore. Company has a reported net profit after tax of Rs 154.28 crore in latest quarter.

Promoter/FII Holdings
Promoters held 55.91 per cent stake in the company as of March 31, 2020, while FIIs held 7.18 per cent, DIIs 14.35 per cent and public and other 22.35 per cent.

(Whats moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

Write us

Find us at the office

Blotner- Kwas street no. 55, 39246 Canberra, Australia

Give us a ring

Dymon Rothfuss
+78 715 483 676
Mon - Fri, 10:00-22:00

Write us